Mirum Pharmaceuticals, Inc. (MIRM)
98.62
-2.05
(-2.04%)
USD |
NASDAQ |
May 22, 16:00
98.58
-0.04
(-0.04%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Assets (Quarterly) : 890.92M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 8.591B |
| Ionis Pharmaceuticals, Inc. | 3.450B |
| AnaptysBio, Inc. | 329.68M |
| BridgeBio Pharma, Inc. | 1.371B |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 648.42M |
| Shareholders Equity (Quarterly) | 242.49M |
| Debt to Equity Ratio | 1.335 |
| Current Ratio | 2.087 |
| Net Debt Paydown Yield | -0.02% |